Intuitive Surgical, Inc. (NASDAQ:ISRG) Insider Sells $1,386,672.00 in Stock

Key Points

• Insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical at an average price of $495.24, resulting in a 13.13% decrease in his ownership position.
• Intuitive Surgical reported a 21.4% increase in quarterly revenue compared to last year, with earnings per share at $2.19, surpassing analysts' estimates by $0.26.
• Analysts have recently adjusted their price targets for Intuitive Surgical, with an average target of $592.05 and a consensus rating of "Moderate Buy."

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) insider Gary S. Guthart sold 2,800 shares of the firm's stock in a transaction that occurred on Monday, July 28th. The stock was sold at an average price of $495.24, for a total transaction of $1,386,672.00. Following the completion of the transaction, the insider directly owned 18,520 shares in the company, valued at $9,171,844.80. This trade represents a 13.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $1.57 during trading on Friday, hitting $482.66. The company's stock had a trading volume of 957,276 shares, compared to its average volume of 1,990,458. The business has a 50 day moving average price of $525.14 and a two-hundred day moving average price of $533.73. The company has a market capitalization of $173.02 billion, a PE ratio of 67.18, a P/E/G ratio of 5.25 and a beta of 1.64. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company's revenue for the quarter was up 21.4% on a year-over-year basis. During the same period in the previous year, the company earned $1.78 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Evercore ISI raised their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a research note on Tuesday, July 8th. BTIG Research raised their target price on shares of Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Truist Financial raised their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. Royal Bank Of Canada raised their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 23rd. Finally, Robert W. Baird decreased their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $592.05.

Institutional Investors Weigh In On Intuitive Surgical

Several institutional investors have recently modified their holdings of the company. Brighton Jones LLC lifted its position in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. Bank Pictet & Cie Europe AG lifted its position in Intuitive Surgical by 0.5% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after acquiring an additional 883 shares during the last quarter. New Age Alpha Advisors LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at $1,098,000. Level Four Advisory Services LLC lifted its position in Intuitive Surgical by 18.3% in the fourth quarter. Level Four Advisory Services LLC now owns 894 shares of the medical equipment provider's stock valued at $467,000 after acquiring an additional 138 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in Intuitive Surgical by 11.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 369,968 shares of the medical equipment provider's stock valued at $193,108,000 after acquiring an additional 37,063 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.